BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2014
View Archived Issues
UC MSCs show potential in clinical study for SLE
Read More
Roche updates pipeline developments of second quarter 2014
Read More
Medigen Biotechnology reports data from interim analysis of the phase III trial Patron
Read More
Study of BTT-1023 in primary sclerosing cholangitis awarded external grant funding
Read More
AstraZeneca and Qiagen to develop test for patients suitable for Iressa treatment
Read More
Lion Biotechnologies signs license agreement with Moffitt for TIL production technologies
Read More
AstraZeneca and Roche to develop companion diagnostic test for AZD-9291
Read More
Retroscreen Virology conducts hVIVO human challenge model study of Al-8176 in RSV
Read More
BiOasis' siRNA-Transcendpep reduces target gene expression in brain
Read More
Akers signs feasibility deal with Konica Minolta to develop cardiac muscle tissue damage test
Read More
Advanced Biological Laboratories and Roche Diagnostics renew and extend collaboration
Read More
KaloBios regains rights to KB-001A and updates on pipeline progress
Read More
AbbVie reviews pipeline activities of second quarter 2014
Read More
EMA committee recommends approval of Baraclude for pediatric patients with HBV
Read More
PoC viral gene therapy to rescue disease phenotype in tachycardiac mice
Read More
European Commission approves Eliquis for deep vein thrombosis and pulmonary embolism
Read More
Rationale for host-directed immunotherapy to treat M. tuberculosis infection
Read More
Cardioxyl advances CXL-1427 for decompensated heart failure after promising phase I trial
Read More
Targacept discontinues TC-5214 for overactive bladder
Read More
Rempex Pharmaceuticals discloses new beta-lactamase inhibitors
Read More
Roche's Gazyvaro approved in Europe for chronic lymphocytic leukemia
Read More
Korean researchers prepare new TGM2 inhibitors
Read More
New radiopharmaceutical metal complexes reported by Molecular InSight Pharmaceuticals
Read More
Incyte patents novel PIM kinase inhibitors
Read More
Novartis patent describes salts of DGAT1 inhibitor
Read More
FDA approves IND for ProHema in children with inherited metabolic disorders
Read More
FDA approves Eylea for diabetic macular edema
Read More